HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

W M Armstead Selected Research

nociceptin

7/2001Nociceptin/orphanin FQ contributes to hypoxic/ischemic impairment of hypercapnic cerebrovasodilation.
6/2001Age-Dependent vasopressinergic modulation of Noc/oFQ-induced impairment of NMDA cerebrovasodilation after brain injury.
1/2001Age dependent endothelin contribution to NOC/oFQ induced impairment of NMDA cerebrovasodilation after brain injury.
12/2000Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury.
11/2000Role of cAMP and K(+) channel-dependent mechanisms in piglet hypoxic/ischemic impaired nociceptin/orphanin FQ-induced cerebrovasodilation.
11/2000NOC/oFQ contributes to age-dependent impairment of NMDA-induced cerebrovasodilation after brain injury.
9/2000Role of nociceptin/orphanin FQ in age-dependent cerebral hemodynamic effects of brain injury.
8/2000Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury.
3/2000Altered release of prostaglandins contributes to hypoxic/ischemic impairment of NOC/oFQ cerebrovasodilation.
2/2000Relationship between nociceptin/orphanin FQ and cerebral hemodynamics after hypoxia-ischemia in piglets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


W M Armstead Research Topics

Disease

12Brain Injuries (Brain Injury)
01/2004 - 06/2000
6Anoxia (Hypoxia)
07/2001 - 01/2000
5Ischemia
07/2001 - 02/2000
1Intracranial Vasospasm
01/2004
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2004
1Spasm (Spasms)
01/2004
1Stroke (Strokes)
01/2004
1Hypercapnia
07/2001
1Brain Ischemia (Cerebral Ischemia)
03/2000

Drug/Important Bio-Agent (IBA)

10nociceptinIBA
07/2001 - 02/2000
5CalciumIBA
10/2001 - 01/2000
5N-Methylaspartate (NMDA)IBA
06/2001 - 06/2000
4Superoxides (Superoxide)IBA
10/2001 - 08/2000
4Adenosine Triphosphate (ATP)IBA
10/2001 - 12/2000
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2001 - 08/2000
4Vasopressins (Vasopressin)IBA
08/2001 - 12/2000
3Endothelins (Endothelin)IBA
01/2004 - 01/2001
2Indomethacin (Indometacin)FDA LinkGeneric
10/2001 - 08/2001
2Cromakalim (Levcromakalim)IBA
10/2001 - 08/2001
2Carbon MonoxideIBA
06/2000 - 03/2000
1nociceptin receptorIBA
07/2001
1salicylhydroxamic acid (SHAM)IBA
07/2001
1Potassium Channels (Potassium Channel)IBA
06/2001
1Protein Kinase CIBA
06/2001
1Endothelin-1 (Endothelin 1)IBA
01/2001
1ChloraloseIBA
09/2000
1Superoxide DismutaseIBA
08/2000
1Methionine EnkephalinIBA
06/2000
1Prostaglandins F (PGF)IBA
03/2000
1ProstaglandinsIBA
03/2000
1iberiotoxinIBA
01/2000